Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 272.4 million compared to CNY 267.33 million a year ago. Revenue was CNY 272.4 million compared to CNY 267.33 million a year ago.

Net income was CNY 45.5 million compared to CNY 36.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.07. Diluted earnings per share from continuing operations was CNY 0.07.